Concurrently, in intrahepatic cholangiocarcinoma (ICC), plasma cells characterised by IGHG1 and JCHAIN, alongside immune cell infiltration, portend improved survival rates [41]. The gene discussed is IGHG1; the disease is intrahepatic cholangiocarcinoma.